Neuralink is set to begin a groundbreaking clinical trial in October 2025, offering hope to individuals with severe speech impairments. The FDA-cleare ...

Neuralink's CEO said this type of device will eventually enable people to interact with large language models (LLMs) without ...

Neuralink Corp., Elon Musk’s brain implant company, plans to launch a clinical trial in the US in October aiming to use its ...

Neuralink plans to begin another US clinical trial in October, using the implant to translate thoughts into text. The study ...

This time, Zuckerberg performed the demo himself, showcasing the new neural band technology, which he calls a "huge ...

Elon Musk's Neuralink plans a US clinical trial in October to translate thoughts into text. The company also aims to implant its device in a healthy individual by 2030.

Bone 02, an injectable, dissolvable bio-adhesive, claims to join broken bones in 3 minutes. Doctors are are sceptical as ...

Geared toward small businesses, the agent can handle everything from suggesting product taglines to generating custom music and voiceovers.

For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to a study.

Abstract: Alzheimer’s disease (AD) stands as the predominant cause of dementia, characterized by a gradual decline in speech and language capabilities. Recent deeplearning advancements have ...

Abstract: Data augmentation (DA) can significantly strengthen the electroencephalogram (EEG)-based seizure prediction methods. However, existing DA approaches are just the linear transformations of ...